TRDA - Entrada Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TRDA is currently covered by 3 analysts with an average price target of $20. This is a potential upside of $9.7 (203.03%) from yesterday's end of day stock price of $6.6.

Entrada Therapeutics's activity chart (see below) currently has 34 price targets and 30 ratings on display. The stock rating distribution of TRDA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 28.33% with an average time for these price targets to be met of 89.75 days.

Highest price target for TRDA is $23, Lowest price target is $17, average price target is $20.

Most recent stock forecast was given by from HC WAINWRIGHT on 08-May-2026. First documented stock forecast 24-Nov-2021.

Best performing analysts who are covering TRDA - Entrada Therapeutics:

Raghuram Selvaraju Boobalan Pachaiyappan Chris Shibutani Francois Brisebois Hartaj Singh

Currently out of the existing stock ratings of TRDA, 4 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 03-Apr-2023

$20

2 months 6 days ago
(08-May-2026)

5/15 (33.33%)

$8.96 (81.16%)

175

Buy Since 26-Aug-2024

$23

$15.26 (197.16%)

$30

3 months 8 days ago
(06-Apr-2026)

0/4 (0%)

$9.12 (65.71%)

Buy Since 03-Apr-2023

$17

$9.26 (119.64%)

$20

11 months 7 days ago
(07-Aug-2025)

3/10 (30%)

$11.7 (220.75%)

177

Buy Since 05-Jan-2024

$30

$18.07 (151.47%)

$28

1 years 3 months 20 days ago
(24-Mar-2025)

0/3 (0%)

$19.2 (177.78%)

Hold Since 24-Nov-2021

$18

$4.5 (33.33%)

$13

3 years 8 months 6 days ago
(08-Nov-2022)

4/4 (100%)

$-1.2 (-6.25%)

14

Show more analysts

Please expand the browser size to see the chart

What is TRDA (Entrada Therapeutics) average time for price targets to be met?

On average it took 89.75 days on average for the stock forecasts to be realized with a an average price target met ratio 28.33

Which analyst has the current highest performing score on TRDA (Entrada Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on TRDA (Entrada Therapeutics)?

Raghuram Selvaraju has 39 price targets and 32 ratings on TRDA

Which analyst is the currently most bullish on TRDA (Entrada Therapeutics)?

Hartaj Singh with highest potential upside - $18.07

Which analyst is the currently most reserved on TRDA (Entrada Therapeutics)?

Raghuram Selvaraju with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?